StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet
Prescription Required
Introduction of StayHappi Tablet
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
Uses of StayHappi Tablet
Benefits of StayHappi Tablet
In Treatment of Type 2 diabetes mellitus
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of StayHappi Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of StayHappi
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
How to use StayHappi Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
UNSAFE
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is, however, not recommended in patients with severe kidney disease.
Use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is, however, not recommended in patients with severe kidney disease.
Liver
CAUTION
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet should be used with caution in patients with liver disease. Dose adjustment of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet may be needed. Please consult your doctor.
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
What if you forget to take StayHappi Tablet?
If you miss a dose of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet
₹5.56/Tablet
Trivogo 2/0.3mg Tablet
Alembic Pharmaceuticals Ltd
₹15.94/tablet
187% costlier
Wonride MV 2 Tablet
Wonset Healthcare Pvt Ltd
₹12.7/tablet
128% costlier
Glimify-MV 2 Tablet
Fidus Healthcare
₹13/tablet
134% costlier
Zorglim MV 2 mg/500 mg/0.3 mg Tablet
Instanz Life Sciences Pvt Ltd
₹12.8/tablet
130% costlier
Glimpure MV 2.3 Tablet
Arrient Healthcare Pvt Ltd
₹12.9/tablet
132% costlier
Quick tips
StayHappi Tablet
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
FAQs
StayHappi Tablet
What is StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet?
StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.
What are the possible side effects of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet?
The use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet is associated with common side effects like hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions in which StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet should not be taken?
The use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet should be avoided in patients with known allergy to any of the components or excipients of this medicine. The use of this medicine is also avoided in patients with moderate to severe kidney disease and in patients with inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet?
No, it is not safe to take StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet along with alcohol. It may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.
Can the use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet cause hypoglycemia?
Yes, the use of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with it. So, regular monitoring of blood sugar level is important. Always keep glucose tablets, honey or fruit juice with you.
What are the instructions for the storage and disposal of StayHappi Glimepiride+Metformin+Voglibose 2mg/500mg/0.3mg Tablet?
Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Glimepiride. Bridgewater, New Jersey: Sanofi-Aventis U.S. LLC.; 2009. [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company. [Accessed 08 Apr. 2019] (online) Available from:
- Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 08 Apr. 2019] (online) Available from:
- Glimepiride+Metformin+Voglibose [Product Monograph]. Punjab, India: Centaur Pharmaceuticals Pvt. Ltd.; 2018. [Accessed 25 Oct. 2021] (online) Available from:
Marketer details
Name: Sarvagunaushdhi Pvt Ltd
Address: 13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN
Country of origin: India
Lab tests offered by us
Related/Popular tests
10 people viewed this recentlyMRP
₹55.56
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me